Delivery Order 36F79720D0148-36C24524N0461
Award Date 3/27/24
Potential Completion Date 3/29/24
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs (VA) awarded a $10,170 firm-fixed-price delivery order to Harmony Biosciences LLC for the pharmaceutical drug WAKIX 17.8MG 60 DOSES. This order is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. Harmony Biosciences is a for-profit pharmaceutical company that specializes in rare neurological diseases and sleep disorders. The delivery order has a period of...
- The U.S. Department of Veterans Affairs Veterans Integrated Service Network 20 (VISN 20) awarded a delivery order to Harmony Biosciences LLC for the supply of bulk WAKIX 17.8 mg tablets, a pharmaceutical product used to treat excessive daytime sleepiness and cataplexy in narcolepsy patients. This firm fixed-price delivery order, valued at $619,879.33, was awarded on December 1, 2025, with a completion date of June 30, 2026, and will be performed in Pittsburgh, Pennsylvania. The award was...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a for-profit pharmaceutical manufacturer, for the supply of WAKIX 17.8 MG tablets. The order was placed against the VA's Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) and has a potential value of $10,170. The delivery location is in Pittsburgh, PA, and the order is to be completed by April 26, 2024. No set-aside provisions were...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company, for the supply of WAKIX 17.8 mg tablets. The contract, valued at $10,418.14, is issued under the VA's Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and supports the provision of narcolepsy treatment medications to VA healthcare facilities nationwide. Harmony Biosciences LLC holds a $25 million Blanket Purchase Agreement...
- Harmony Biosciences LLC has been awarded a firm fixed price delivery order valued at $10,170 to supply WAKIX 17.8 MG tablets. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 against the General Services Administration Federal Supply Schedule for Pharmaceuticals and Drugs. Performance will take place in Pittsburgh, Pennsylvania by January 31, 2024. No set-aside designation was applied to this order to fulfill...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC for the pharmaceutical product WAKIX 17.8 MG. The order, valued at $10,418.40, was placed against the VA's $5 million Blanket Purchase Agreement with Harmony Biosciences to supply WAKIX, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients, to VA healthcare facilities nationwide. Harmony...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company, to provide WAKIX 17.8 mg tablets. The order, valued at $5,085.00, is issued against Harmony Biosciences' General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) contract. Harmony Biosciences has a $5 million Blanket Purchase Agreement with the VA National Acquisition Center to supply WAKIX, as well as...
- This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company, to supply WAKIX 17.8 mg tablets. The contract has a ceiling value of $10,418.14 and an ultimate completion date of September 12, 2025. The contract is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and does not have a set-aside designation, indicating open competition. Harmony Biosciences LLC is a...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a for-profit pharmaceutical company. The $10,418.14 contract is for the supply of WAKIX 17.8 mg, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of August 6, 2025. No set-aside...
- This federal contract award is a delivery order valued at $656,342.82 issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The award is for the bulk order of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. Harmony...